Rock Springs Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001595725

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2024 · 107 positions · Total reported value $3.07B · Top-10 concentration 34.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 39.8% · 9 new · 28 cut · 8 exited

Active Share (vs S&P 500): 96.8% · vs QQQ: 99.2% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.5% · vs SPY -9.6% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.4% · vs SPY -4.5% · Latest Value $1.85B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2024 13F filing, Rock Springs Capital Management LP disclosed 107 equity positions with a combined reported value of $3.07B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 34.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2024 were UNH ($172.04M), ISRG ($132.64M), ARGX ($126.58M). By sector, the heaviest allocations are Health Care 81.5%, Consumer Discretionary 3.6%. Versus the prior quarter, allocation shifted toward Other (+2.4pp) and away from Consumer Discretionary (-0.7pp), Health Care (-1.2pp).

Versus the prior quarter, Rock Springs Capital Management LP opened 9 new positions, trimmed 28 and fully exited 8, a turnover rate of 39.8% of positions. The portfolio's overlap with the prior quarter was 89% of names.

The largest new positions opened in Q3 2024 were SMMT ($22.78M), ZBIO ($14.87M), BCAX ($11.36M).

Of the 8 positions fully exited versus the prior quarter, the largest were IDXX ($58.22M), IMCR ($14.20M), OLK ($12.74M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • SMMT SUMMIT THERAPEUTICS INC · $22.78M
  • ZBIO ZENAS BIOPHARMA INC · $14.87M
  • BCAX BICARA THERAPEUTICS INC · $11.36M
  • CYTK CYTOKINETICS INC · $10.88M
  • XNCR XENCOR INC · $8.06M
  • NAMS NEWAMSTERDAM PHARMA COMPANY · $5.87M

Fully Exited (vs previous quarter)

  • IDXX IDEXX LABS INC · prev qtr: $58.22M
  • IMCR IMMUNOCORE HLDGS PLC · prev qtr: $14.20M
  • OLK OLINK HLDG AB · prev qtr: $12.74M
  • CRL CHARLES RIV LABS INTL INC · prev qtr: $12.45M
  • FULC FULCRUM THERAPEUTICS INC · prev qtr: $4.51M
  • MLYS MINERALYS THERAPEUTICS INC · prev qtr: $4.43M · history

Insider Transactions (Form 4)

Latest Rock Springs Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rock Springs Capital Management LP is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q2 2026 it reported 104 US equity positions with a combined value of $2.05B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BALTIMORE, MD, United States
  • SEC registration: 801-78511 (status: Approved), registered 2013-09-27
  • Regulatory AUM (Form ADV): $2.43B as of 2026-03-24
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 104 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 44.0% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 10.1%
  • Average position size: $19.70M

Sector Tilt

  • Health Care 96.8%
  • Industrials 1.1%
  • Consumer Discretionary 1.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 16 new, 35 added, 31 reduced, 12 exited
  • 22 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 81.5%
Technology 0.8%
Materials 0.1%
Other 12.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 294.25K $172.04M 5.61%
5.61%
Add
2 270.00K $132.64M 4.32%
4.32%
Reduce
3 233.50K $126.58M 4.12%
4.12%
Add
4 142.00K $125.80M 4.10%
4.10%
Add
5 1.98M $109.89M 3.58%
3.58%
Add
6 939.00K $108.19M 3.53%
3.53%
Hold
7 1.15M $78.17M 2.55%
2.55%
Add
8 768.78K $71.11M 2.32%
2.32%
Add
9 250.00K $68.76M 2.24%
2.24%
Hold
10 4.68M $65.54M 2.14%
2.14%
Add
11 1.23M $64.34M 2.10%
2.10%
Reduce
12 1.58M $61.64M 2.01%
2.01%
Reduce
13 446.50K $61.07M 1.99%
1.99%
Reduce
14 2.07M $58.54M 1.91%
1.91%
Reduce
15 263.06K $55.83M 1.82%
1.82%
Add
16 2.28M $52.02M 1.70%
1.70%
Reduce
17 1.32M $51.83M 1.69%
1.69%
Add
18 815.00K $51.68M 1.68%
1.68%
Reduce
19 265.00K $51.49M 1.68%
1.68%
Hold
20 167.75K $50.35M 1.64%
1.64%
Add
21 683.34K $49.88M 1.63%
1.63%
Reduce
22 1.05M $49.67M 1.62%
1.62%
Reduce
23 325.00K $48.53M 1.58%
1.58%
Add
24 148.00K $46.88M 1.53%
1.53%
Hold
25 1.06M $46.70M 1.52%
1.52%
Add
26 1.01M $45.80M 1.49%
1.49%
Add
27 892.55K $44.59M 1.45%
1.45%
Reduce
28 429.99K $43.99M 1.43%
1.43%
Add
29 9.53M $39.19M 1.28%
1.28%
Add
30 460.00K $38.55M 1.26%
1.26%
Reduce
31 307.50K $38.40M 1.25%
1.25%
Add
32 576.90K $38.07M 1.24%
1.24%
Add
33 1.10M $37.52M 1.22%
1.22%
Reduce
34 9.10M $35.75M 1.17%
1.17%
Add
35 524.00K $35.13M 1.15%
1.15%
Add
36 1.22M $34.82M 1.14%
1.14%
Add
37 1.32M $31.76M 1.03%
1.03%
Add
38 134.00K $31.19M 1.02%
1.02%
Reduce
39 699.39K $31.07M 1.01%
1.01%
Reduce
40 397.50K $29.51M 0.96%
0.96%
Hold
41 114.50K $29.12M 0.95%
0.95%
Reduce
42 3.62M $27.53M 0.90%
0.90%
Hold
43 130.00K $27.44M 0.89%
0.89%
Hold
44 933.40K $26.78M 0.87%
0.87%
Reduce
45 532.50K $25.79M 0.84%
0.84%
Reduce
46 508.93K $24.80M 0.81%
0.81%
Add
47 1.44M $23.50M 0.77%
0.77%
Reduce
48 1.04M $22.78M 0.74%
0.74%
New
49 3.10M $21.71M 0.71%
0.71%
Reduce
50 1.01M $21.45M 0.70%
0.70%
Reduce

FAQ

What did Rock Springs Capital Management LP buy in 2024-Q3?

In its 2024-Q3 13F filing, Rock Springs Capital Management LP reported 107 equity positions worth $3.07B in aggregate; its largest disclosed positions were UNH ($172.04M), ISRG ($132.64M), ARGX ($126.58M).

How large is Rock Springs Capital Management LP's portfolio?

Rock Springs Capital Management LP reported $3.07B of long equity holdings across 107 positions as of 2024-Q3. Top-10 holdings account for 34.5% of reported value.

What is Rock Springs Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rock-springs-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →